HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

Autor: Ismael, Nália1,2 (AUTHOR) nalia.ismael@ins.gov.mz, Gemusse, Hernane1 (AUTHOR), Mahumane, Isabel1 (AUTHOR), Laurindo, Osvaldo1 (AUTHOR), Magul, Cacildo1 (AUTHOR), Baxter, Cheryl3 (AUTHOR), Wilkinson, Eduan3 (AUTHOR), Hofstra, L. Marije3 (AUTHOR), Wagar, Nick4 (AUTHOR), Bila, Dulce5 (AUTHOR), Mabunda, Nédio1 (AUTHOR), da Silva, Juliana4 (AUTHOR), Oliveira, Túlio de3 (AUTHOR), Raizes, Elliot4 (AUTHOR), Preiser, Wolfgang2 (AUTHOR), Manuel, Pedro6 (AUTHOR), Ramos, Artur6 (AUTHOR), Vúbil, Adolfo1 (AUTHOR)
Zdroj: BMC Infectious Diseases. 7/29/2024, Vol. 24 Issue 1, p1-9. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje